Clinical Trial Update: Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study comparing low molecular weight heparin with unfractionated heparin for embolic stroke, with the current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Embolic Stroke | Phase 2 | Status: UNKNOWN